Page results
-
HTD Outpatients offers a wide range of clinics for Chagas disease, Infectious diseases, Leishmaniasis, Leprosy , Malaria , Microbiology, Neglected tropical diseases, Parasitology
-
This page explains more about the Prostate One-Day Clinic and what you can expect when you come for your appointment. If you have any questions about your appointment or the information included on this page, please contact one of our prostate clinical nurse specialists (CNSs).
-
This page explains how PIFU will work for you once you have finished your treatment for lymphoma.
-
This page answers common questions about Acute Pancreatitis and how it is managed in North Central London (NCL).
-
This page provides information about anaesthesia for children having proton beam therapy.
-
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched at UCLH,
-
This page explains what vaginal dilation therapy is and includes a step-by-step guide to how it should be performed. If you have any questions, please talk to your healthcare team.
-
The service includes diagnosis, quantifying the degree of hearing loss, and rehabilitation of hearing impairment to limit participation restriction.
-
This page provides information on Ulcerative Colitis (UC) and how diet can help you manage any symptoms you are managing, improve wellbeing and support a healthy diet during remission.
-
This page provides information on how diet can help to manage the symptoms of Ulcerative Colitis during a flare up known as active Ulcerative Colitis.
File results
-
FOI/2023/0501 - Central Airway Tumour Management/ Endobronchial Valves for treatment of Emphysema
-
FOI/2023/0505 - Telecommunications infrastructure contract
-
FOI/2023/0507 - Mental health patient suicides
-
FOI/2023/0508 - Lynch syndrome clinical pathway
-
FOI/2023/0509 - Immunoglobulin treatments
-
FOI/2023/0514 - Processes and software applications used in Urology
-
FOI/2023/0516 - Maternity management system
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0537 - Agency usage for the Occupational Therapy